Collections

Business on the Front Lines

News and perspectives from corporations working to directly impact the COVID-19 public health crisis. Content from this collection may include updates from medical supply or pharmaceutical companies, businesses that have pivoted their production to support the medical response to COVID-19 or hospitals that are navigating many secondary impacts of the pandemic (both economic and human).

Pharmacies Add Freezers, Train Staff to Handle Covid-19 Vaccination Drive

Pharmacies Add Freezers, Train Staff to Handle Covid-19 Vaccination Drive

By: Jaewon Kang
Source: Wall Street Journal
Date of Publication: November 29th, 2020
Supermarkets are rushing to secure freezers, thermometers and other medical gear for administering shots. They are also training staff and establishing online services for scheduling appointments.
Ride-share companies have been hit hard by Covid-19. Drivers received free meals, hand sanitizer and face masks at a food drive in Burbank, Calif. in June last year.

Uber, Lyft Push Biden Team for Role in Covid-19 Vaccine Rollout

By: Emily Glazer, Sarah Krouse
Source: Wall Street Journal
Date of Publication: January 12th, 2021
Ride-sharing companies seek early access to doses for workers, offer to take passengers to get their shots
CVS Health, Walgreens start to provide Covid vaccines at thousands of hard-hit nursing homes

CVS Health, Walgreens start to provide Covid vaccines at thousands of hard-hit nursing homes

By: Melissa Repko
Source: CNBC
Date of Publication: December 18th, 2020
CVS Health and Walgreens are starting to give Covid-19 vaccinations to residents and staff at nursing homes and assisted living facilities, making them among the first Americans to receive the shots.
Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them - WSJ

Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them

By: Elizabeth Koh
Source: The Wall Street Journal
Date of Publication: January 4th, 2021
Companies mass producing shots for Pfizer, Moderna and AstraZeneca are racing to find staff: ‘We are truly in unprecedented territory’
J&J enrolls about 45,000 participants for late-stage Covid vaccine trial

J&J enrolls about 45,000 participants for late-stage Covid vaccine trial

By: Reuters
Source: CNBC
Date of Publication: December 18th, 2020
Johnson & Johnson said it has enrolled about 45,000 participants for the first late-stage trial of its Covid-19 single-dose vaccine candidate.
Pfizer, U.S. Reach Deal to Boost Covid-19 Vaccine Supply

Pfizer, U.S. Reach Deal to Boost Covid-19 Vaccine Supply

By: Peter Loftus, Rebecca Ballhaus and Matt Grossman
Source: The Wall Street Journal
Date of Publication: December 23rd, 2020
Company will provide 100 million more doses to bolster campaign under way in U.S.
FDA Finds Moderna Covid-19 Vaccine Highly Effective

FDA Finds Moderna Covid-19 Vaccine Highly Effective

By: Thomas M. Burton and Peter Loftus
Source: The Wall Street Journal
Date of Publication: December 15th, 2020
Second major U.S. coronavirus vaccine could possibly be shipped by this weekend.
FDA chief says agency will quickly approve Pfizer's Covid vaccine for emergency use

FDA chief says agency will quickly approve Pfizer’s Covid vaccine for emergency use

By: Noah Higgins-Dunn and Will Feuer
Source: CNBC
Date of Publication: December 11th, 2020
FDA Commissioner Stephen Hahn tweeted Friday that the agency “is finalizing the necessary documents to ensure that patients and providers have the information that they need to make informed decisions.”
Pfizer building

FDA Says Pfizer-BioNTech Vaccine Is Safe, Effective

By: Thomas M. Burton and Jared S. Hopkins
Source: The Wall Street Journal
Date of Publication: December 8th, 2020
The Food and Drug Administration said the first Covid-19 vaccine being considered for U.S. distribution “met the prescribed success criteria” in a clinical study, paving the way for the agency to green-light distribution as early as this weekend.
First batch of 6.4 million vaccine doses could go out in mid-December - The Washington Post

First 6.4 million doses of Pfizer’s coronavirus vaccine could go out in mid-December

By: Lena H. Sun
Source: The Washington Post
Date of Publication: November 24th, 2020
The federal government plans to send 6.4 million doses of pharmaceutical giant Pfizer’s coronavirus vaccine to communities across the United States within 24 hours of regulatory clearance, with the expectation that shots will be administered quickly to front-line health-care workers, the top priority group, officials said Tuesday.

Browse Collections

  • The Changing Nature of Work COVID-19

    The Changing Nature of Work

    From virtual offices to essential workers, explore how companies are adapting to changes in the way we work.
    Read More
  • Business on the Front Lines COVID-19

    Business on the Front Lines

    News and perspectives from corporations rising to the challenge of the COVID-19 public health crisis.
    Read More
  • Leading in a Crisis COVID-19.

    Leading in a Crisis

    Uncertainty can be disorienting and disruptive. Learn from business leaders about what it’s like to navigate their organizations and people through a global pandemic.
    Read More
  • Service and Community COVID-19

    Service and Community

    We’re in this together. Discover ways corporations are serving their communities and pivoting to become essential services.
    Read More